Their subsequent studies identified that G-CSF via activation of STAT3 promoted NB tumorigenicity and metastasis (43, 44), raising the possibility that small molecule inhibitors of the JAK/STAT pathway that were being developed for other cancers may selectively target these highly aggressive NB tumor cells. This evidence concerns the gene CSF3 and neuroblastoma.